title: Complicated and Advanced Atherosclerosis in a Young Woman With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Success and Challenges of BCR/ABL1-Targeted Cancer Therapy.
authors.affiliation: Mayo Clinic, Rochester, Minnesota.
authors.forename: Joerg
authors.initials: J
authors.lastname: Herrmann
authors.affiliation: Mayo Clinic, Rochester, Minnesota.
authors.forename: Malcolm R
authors.initials: MR
authors.lastname: Bell
authors.affiliation: Mayo Clinic, Rochester, Minnesota.
authors.forename: Rebekkah L
authors.initials: RL
authors.lastname: Warren
authors.affiliation: Mayo Clinic, Rochester, Minnesota.
authors.forename: Amir
authors.initials: A
authors.lastname: Lerman
authors.affiliation: Mayo Clinic, Rochester, Minnesota.
authors.forename: Mark D
authors.initials: MD
authors.lastname: Fleming
authors.affiliation: Mayo Clinic, Rochester, Minnesota.
authors.forename: Mrinal
authors.initials: M
authors.lastname: Patnaik
mesh_terms: D000328:Adult; D050197:Atherosclerosis / Q000150:complications*; D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000037:antagonists & inhibitors* / Q000378:metabolism; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications* / Q000188:drug therapy* / Q000378:metabolism; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011724:Pyridazines / Q000627:therapeutic use*
chemical_list: D007093:Imidazoles; D047428:Protein Kinase Inhibitors; D011724:Pyridazines; C545373:ponatinib; D016044:Fusion Proteins, bcr-abl